Can solar technology kill cancer cells?

Scientific breakthroughs don’t always happen in labs. For Sophia and Richard Lunt, Michigan State University researchers, many of their breakthroughs happen during neighborhood walks.

The married couple’s step-by-step approach has revealed a new way to detect and attack cancer cells using technology traditionally reserved for solar power. The results, published in the current issue of Scientific Reports, showcases dramatic improvements in light-activated fluorescent dyes for disease diagnosis, image-guided surgery and site-specific tumor treatment.

“We’ve tested this concept in breast, lung cancer and skin cancer cell lines and mouse models, and so far it’s all looking remarkably promising,” said Sophia, MSU biochemistry and molecular biologist.

While the cancer applications hold the most possibility, their findings have potential beyond the field of oncology, said Richard, the Johansen Crosby Endowed Professor of chemical engineering and materials science.

“This work has the potential to transform fluorescent probes for broad societal impact through applications ranging from biomedicine to photocatalysis — the acceleration of chemical reactions with light,” he said. “Our solar research inspired this cancer project, and in turn, focusing on cancer cells has advanced our solar cell research; it’s been an amazing feedback loop.”

Prior to the Lunts’ combined effort, fluorescent dyes used for therapeutics and diagnostics, aka “theranostics,” had shortcomings, such as low brightness, high toxicity to cells, poor tissue penetration and unwanted side effects.

By optoelectronically tuning organic salt nanoparticles used as theranostics, the Lunts were able to control them in a range of cancer studies. Coaxing the nanoparticles into the nontoxic zone resulted in enhanced imaging, while pushing them into the phototoxic — or light-activated — range produced effective on-site tumor treatment.

The key was learning to control the electronics of their photoactive molecules independently from their optical properties and then making the leap to apply this understanding in a new way to a seemingly unrelated field.

Richard had recently discovered the ability to electronically tune these salts from his work in converting photovoltaics into solar glass. Sophia had long studied metabolic pathways unique to cancer cells. It was when the Lunts were discussing solar glass during a walk that they made the connection: Molecules active in the solar cells might also be used to more effectively target and kill cancer cells.

A journey of 1,000 miles

Their walks had rather unscientific beginnings. Shortly after the Lunts met at Princeton University, Richard moved to another university. To maintain their long-distance relationship, they scheduled daily phone calls. Upon their arrival at MSU, individual academic career demands replaced geographic distance as a challenge to their busy lives.

To connect daily, they take CEO-style walks together every evening. The two-mile saunters take place rain or shine, and they often engage in scientific discussions. The three keys to their walks are intentional curiosity, perseverance and the merging of different fields and perspectives, Sophia said.

“We talk science, strategic plans for our careers and our various grants,” she said. “We ping ideas off each other. Our continual conversations brainstorming ideas on a particular topic or challenge often lead to those exciting ‘aha’ moments.”

Their walks have helped them push through many challenges.

“Our first experiments did not turn out as expected; I’m surprised that we didn’t give up given how crazy the idea seemed at first,” Richard said. “Figuring out how to do this research took many walks.”

Obviously, the results were worth the hike. Today, Richard designs the molecules; Babak Borhan, MSU chemist, synthesizes and improves them; and Sophia tests their photoactive inventions in cancer cell lines and mouse models.

Future research will work to improve the theranostics’ effectiveness, decrease toxicity and reduce side effects. The Lunts have applied for a patent for their work, and they’re looking forward to eventually pushing their photoactive molecule findings through clinical trials.

“Though that will take many more walks,” Richard said with a smile.

Share Button

High fiber, yogurt diet associated with lower lung cancer risk

A diet high in fiber and yogurt is associated with a reduced risk for lung cancer, according to a study by Vanderbilt University Medical Center researchers published in JAMA Oncology.

The benefits of a diet high in fiber and yogurt have already been established for cardiovascular disease and gastrointestinal cancer. The new findings based on an analysis of data from studies involving 1.4 million adults in the United States, Europe and Asia suggest this diet may also protect against lung cancer.

Participants were divided into five groups, according to the amount of fiber and yogurt they consumed. Those with the highest yogurt and fiber consumption had a 33% reduced lung cancer risk as compared to the group who did not consume yogurt and consumed the least amount of fiber.

“Our study provides strong evidence supporting the U.S. 2015-2020 Dietary Guideline recommending a high fiber and yogurt diet,” said senior author Xiao-Ou Shu, MD, PhD, MPH, Ingram Professor of Cancer Research, associate director for Global Health and co-leader of the Cancer Epidemiology Research Program at Vanderbilt-Ingram Cancer Center.

“This inverse association was robust, consistently seen across current, past and never smokers, as well as men, women and individuals with different backgrounds,” she added.

Shu said the health benefits may be rooted in their prebiotic (nondigestible food that promotes growth of beneficial microorganisms in the intestines) and probiotic properties. The properties may independently or synergistically modulate gut microbiota in a beneficial way.

The study’s lead authors are Jae Jeong Yang, PhD, a visiting research fellow from the Seoul National University, South Korea, and Danxia Yu, PhD, assistant professor of Medicine at Vanderbilt.

 

Story Source:

Materials provided by Vanderbilt University Medical Center. Note: Content may be edited for style and length.

Share Button

Health24.com | Flavours draw young people to lifetime addiction of vaping

Tasty flavours entice young people to try e-cigarettes, getting them hooked on what can become a lifetime habit, a new study shows.

“Children and youth prefer sweet flavours. We know that flavours increase appeal to young or inexperienced users,” said lead researcher Andrea Villanti, an associate professor with the University of Vermont’s Center on Behavior and Health. “Something that tastes like candy is more palatable to a young person than tobacco flavour on its own.”

Only tobacco and menthol flavours

Her team found that young people who first try a flavoured vape, cigar or smokeless tobacco are much more likely to still be using that product a year later.

For example, twice as many kids and young adults who first try a flavoured e-cigarette will still be vaping a year later, compared with those who first try a tobacco-flavoured vape, the study found.

The results support recent efforts by the Trump administration and some states to ban flavoured e-cigarettes.

In response to growing pressure, e-cigarette maker Juul announced last week that it would suspend sales of all flavoured pods for its vaping device. Only tobacco and menthol flavours will remain on the market, pending review by the US Food and Drug Administration.

But Villanti noted that the problem extends far beyond vaping.

“E-cigarettes are getting a lot of attention right now, and they also have a lot of flavours, but this is a problem we have across all product categories,” Villanti said. “It’s not just an e-cigarette issue.”

Ongoing federally funded study

Regulations against flavourings in tobacco products remain weak, Villanti said. Cigarettes are the only tobacco product in which flavours are banned, although menthol cigarettes have been allowed to remain on the market.

To see whether flavours attract young people to tobacco and then help keep them using, Villanti and her team used data from an ongoing federally funded study that tracks tobacco use in the United States.

The researchers assessed data collected in 2013–2014 to see whether people are more likely to first try a flavoured e-cigarette or other tobacco product. They then looked at data gathered a year later to see if those who first tried a flavoured product were still using tobacco.

Seven out of 10 kids who were new users of tobacco first tried a flavoured product, as well as more than half of young adults, researchers found.

Those young adults who started with a flavoured product were more likely to stick with it, data from the second wave revealed. Current daily users included:

  • Twice as many first-time users of flavoured e-cigarettes or pipe tobacco
  • Three and a half times as many filtered cigar users
  • Twice as many hookah tobacco users
  • Half again as many users of cigarillos, cigars or smokeless tobacco

Even more compelling data

“If you’re younger than 25, the first product you probably use is flavoured and you’re more likely to continue to use tobacco products if you’re introduced to a flavoured product first,” said Dr Jamie Rutland, who reviewed the study. He’s an assistant clinical professor of pulmonology and critical care at the University of California, Riverside.

Adults also were more likely to keep using a tobacco product if they first tried a flavoured version, the study showed.

The new study “confirms what everybody already thought,” Rutland said, adding that flavours have contributed to the recent boom in vaping.

“This was a study done five years ago, when they collected the data,” noted Rutland, an American Lung Association national spokesman. “I think the data, if they collected it now, would be even more compelling.”

The new study was published in the journal JAMA Network Open.

Image credit: iStock

Share Button

Cells linked to leading cause of blindness in elderly

Age-related macular degeneration is one of the leading causes of blindness in the elderly, affecting more than 2 million people in the United States and leading to progressive loss of central vision. Genome wide studies have identified almost three dozen genes that play a role in the disease, but exactly where in the eye they inflict damage was not well known.

Researchers from Yale University, the Broad Institute of the Massachusetts Institute of Technology, and Harvard University report in the Oct. 25 issue of the journal Nature Communications that glial cells (or support cells), and vasculature cells tasked with providing blood to the retina as well as cone cells contribute to degeneration of the macula, in the central part of the retina.

“This study helps pinpoint cell types that can be investigated closely to develop new types of therapeutics,” said co-senior author Brian Hafler, assistant professor of ophthalmology and visual science and of pathology at Yale.

There are a limited number of effective long-term treatments available for the two forms of macular degeneration. The wet form is caused by growth of abnormal blood vessels underneath the macula, which can be mitigated by regular injections in the eye. Other than eye vitamin supplements, there is no treatment for the dry form of the disease, which is marked by accumulations of yellow deposits called drusen in the macula. While current treatments provide some benefits, over time there can be a continued, progressive loss of vision in both forms of the disease.

While genes associated with the risk of developing macular degeneration had been identified, the Yale/Harvard/MIT team used new single-cell sequencing to generate the first comprehensive human retinal atlas and employed data analysis technology to localize their effects to specific cell types associated with the disease.

While they found risk genes associated with cones, the cell type key to central vision, the researchers also found an association with glial and vascular cells — providing possible targets for novel therapies to improve and restore vision.

Story Source:

Materials provided by Yale University. Original written by Bill Hathaway. Note: Content may be edited for style and length.

Share Button

Advance in search for new Clostridioides difficile vaccine

Scientists have made a breakthrough in the hunt for a new vaccine for killer hospital bug Clostridioides difficile (C. diff).

University of Exeter researchers first identified a gene in C. diff responsible for producing a protein that aids in binding the bacteria to the gut of its victims.

In collaboration with researchers at Paris-SUD University, they then showed that mice vaccinated with this protein generated specific antibodies to the protein — and that C. diff that did not produce this protein were less able to attach to the gut.

C. diff bacteria must bind to the gut to produce the toxin that causes illness, and the Exeter team are hopeful that vaccination against attachment will be effective in humans.

No C. diff vaccine is currently in widespread use. Some toxin-based vaccines are currently in clinical trials, but the Exeter research offers a promising new approach. C. diff infections, which commonly occur in people who have recently taken antibiotics, can cause severe illness and results in thousands of deaths each year, especially among the elderly and other vulnerable groups.

“Infection by C. diff often occurs when the natural gut bacteria are disrupted by antibiotics,” said Dr Stephen Michell, of the University of Exeter.

“With other bacteria missing, C. diff can attach to the gut and release a toxin that causes symptoms including diarrhea.

“We identified a gene — CD0873 — that generates a protein that helps C. diff bind to the gut.

“This binding is thought to be key for C. diff infections, so if we can prevent adhesion of bacteria then there’s a real possibility of preventing this disease.”

The researchers immunised mice with the CD0873 protein in isolation (not as part of a C. diff bacterium) and found a “strong” immune response.

When subsequently exposed to C. diff, these immunised mice were unaffected while non-immunised mice fell ill and lost about 10 percent of their body weight on average.

The research began as a collaboration between the University of Exeter, Novartis and the University of Nottingham, and this latest collaborative study involved the University of Bath and University Paris-Sud.

Both the universities of Bath and Exeter are part of the GW4 Alliance, a collaborative research alliance of research-intensive and innovative universities in the South West and Wales.

Scientists at University Paris-Sud conducted the experiments that showed that mice develop antibodies when immunised with the CD0873 protein.

The Bath researchers mapped the 3D molecular structure of CD0873 at high resolution using the high-brightness X-ray beam at the UK’s state-of-the-art facility, Diamond Light Source at Didcot in Oxfordshire providing more information on its function.

The new paper, published in the Journal of Biological Chemistry, is entitled: “Molecular features of lipoprotein CD0873: A potential vaccine against the human pathogen Clostridioides difficile.”

A study published in 2015 said C diff caused almost half a million infections in the US in a year, directly leading to 15,000 deaths.

Whilst several C. diff toxin-targeted vaccines are currently in clinical trials, in 2017, pharmaceutical company Sanofi scrapped its efforts to find a toxin-based C. diff vaccine after many years, citing a low probability of success.

This alternative, adhesion-targeting vaccine identified by this important research may be a key new approach to disease control.

Dr Ray Sheridan, a consultant physician at the Royal Devon & Exeter Hospital, said: “A vaccine that stops the C. diff sticking to the gut wall and so stops it making the gut its new home would then stop the bug being able to cause diarrhoea or infection.

“This would need to go through clinical trials but if it worked it would potentially prevent C. diff infection altogether.

“Our current treatments rely on using more antibiotics, and we need to move away from that approach as antibiotics are one of the main causes of the C. diff problem in the first place by interfering with natural gut flora of bacteria.”

Share Button

Warming waters, local differences in oceanography affect Gulf of Maine lobster population

Two new studies published by University of Maine scientists are putting a long-standing survey of the American lobster’s earliest life stages to its most rigorous test yet as an early warning system for trends in New England’s iconic fishery. The studies point to the role of a warming ocean and local differences in oceanography in the rise and fall of lobster populations along the coast from southern New England to Atlantic Canada.

One of the papers, published in the scientific journal “Ecological Applications,” was led by Noah Oppenheim, who completed his research as a UMaine graduate student in 2016, with co-authors Richard Wahle, Damian Brady and Andrew Goode from UMaine’s School of Marine Sciences, and Andrew Pershing from the Gulf of Maine Research Institute. They report that the numbers of young-of-year lobsters populating shallow coastal nursery habitats each year, and temperature, provide a reasonably accurate prediction of trends in the lobster fishery some four to six years later.

Their model predicted regional differences in the recent record-breaking boom over the past decade, and now suggests the Gulf of Maine lobster fishery may be entering a period of decline; in effect a “cresting wave” of lobster abundance that may be heading northward in the region’s changing climate.

“Our model projects that the Gulf of Maine’s lobster landings will return to previous historical levels,” said Oppenheim, who is now executive director of the Pacific Coast Federation of Fishermen’s Associations and the Institute for Fisheries Resources in San Francisco. “These results don’t suggest a lobster crash, but this tool could give the fishing industry and policymakers additional lead time as they make decisions about their businesses and communities in the years ahead.

“We recommend that the stock assessment community and fishery managers use this information in concert with other indicators of the health of the fishery, as an independent early warning system,” Oppenheim said.

The second article, led by current UMaine marine science Ph.D. student Andrew Goode, underscores the importance of local differences in the oceanography of the Gulf of Maine for understanding where the lobster boom occurred.

“We suggest that this increase resulted from a complex interplay between lobster larval settlement behavior, climate change and local oceanographic conditions,” wrote Goode and his co-authors in their paper published in the journal “Global Change Biology.” The paper was co-authored by Brady, Wahle and Robert Steneck, all of the School of Marine Sciences.

Goode and his collaborators observed that an expanded area of thermally suitable habitat for larval settlement in the eastern Gulf of Maine may have helped drive and amplify the lobster boom in the region over the last decade — a boom that elevated the fishery to its current status as the most valuable single-species fishery in the nation. This cooler deepwater habitat may provide refuge for juvenile lobster from the negative impacts of ocean warming and buffer the Maine lobster fishery from similar declines as observed in southern New England.

While the paper points to a “brighter side of climate change” in this case, it does not deny the adverse effects of a warming ocean south of Cape Cod for other species.

At the center of these studies is the American Lobster Settlement Index (ALSI), a long-standing shallow water monitoring study serving as an important indicator of the strength of new lobster year classes repopulating coastal nursery habitats each year. The survey generating the annual index was founded in 1989 by Wahle, a UMaine research professor, director of the Lobster Institute, and co-author of both studies.

The ALSI collaborative includes government marine resource agencies, academic institutions and industry members in New England and Atlantic Canada who undertake and pay for the divers and boats to survey more than 100 sites spanning Rhode Island to Newfoundland. Wahle’s lab serves as the data hub for the survey.

“No one has a crystal ball, but in a field where sweeping statements are made about the global impacts of climate change, these studies underscore the importance of having a fine scale, local, understanding of both oceanography and organism biology as we project the impacts of a changing climate on the future of our coastal communities and economy,” Wahle said.

Story Source:

Materials provided by University of Maine. Note: Content may be edited for style and length.

Share Button

Health24.com | Don’t be fooled by foods that sound healthy but aren’t

You probably already realise that adding zucchini or carrots to a cake won’t magically make it low calorie or healthy. But you might not realise that there are many foods that sound healthy but really aren’t.

It might seem as though bran muffins are the perfect way to get needed fibre, but the 3g in an average bakery offering don’t justify all the white flour, sugar, fat and calories that go along with it. A better breakfast is to mix two tablespoons of wheat bran into hot, steel-cut oatmeal and top it with a handful of raisins.

Laden with salt

Sushi sounds like a great way to enjoy fish, but the ratio of fish to rice – usually white rice – makes the protein portion minuscule (and, ounce for ounce, extremely expensive). Opt for sashimi instead, which is simply slices of raw fish, or ask for brown rice in your rolls. Also, watch the soy sauce – it’s laden with salt – and limit mayonnaise-based spicy sauces that accompany many fancy rolls.

What could be bad about hazelnut and dark chocolate spreads? The problem is that sugar and palm oil are the first two ingredients in many popular store brands. If you love the flavour, dip whole roasted hazelnuts into melted dark chocolate as a treat, or whip up your own spread by blending freshly roasted hazelnuts in a food processor until a paste forms and then folding it into melted chocolate.

Beet and carrot chips sound yummy and should be low-calorie, right? Be aware that vegetable alternatives to potato chips still get more than half their calories from oil. One ounce has the same calories as a 6-ounce sweet potato, but few of the potato’s nutrients. If you want a veggie crunch, oven-bake very thin slices of your favourite vegetables.

Image credit: Luigi Pozzoli on Unsplash

NEXT ON HEALTH24X

Share Button

Patients to stand up at GP appointments in Loughborough University trials

The aim is to shorten consultations and see GPs act as healthier role models.

Share Button

Health24.com | WATCH: An unhealthy obsession with healthy eating

25 October 2019

WATCH: An unhealthy obsession with healthy eating

Do you find yourself constantly feeling guilty if you even look at a slice of pizza?

Stringr

Are you obsessed with defining and maintaining the perfect diet, rather than an ideal weight?

You may be suffering from orthorexia.

While it can be challenging to identify, it is defined as someone with obsessive behaviour in pursuit of a healthy diet.

People who suffer from the condition display signs and symptoms of anxiety disorders that frequently occur alongside other eating disorders.

Image credit: iStock

NEXT ON HEALTH24X

Live healthier

Share Button

Vaccine reminder system ‘inconsistent’, report concludes

A National Audit Office report investigated the reasons for falling pre-school vaccine uptake.

Share Button